Skip to main content
Photo of  Sachie Ikegami, MD,PhD

Sachie Ikegami, MD,PhD

Medical Resident/Fellow

Pathology & Laboratory Medicine | College of Medicine

  • PhD: Tottori University Faculty of Medicine, Department of Brain and Neurosciences
  • MD: Tottori University Faculty of Medicine
Contact Information

Peer Reviewed Publications

Ikegami S, Benirschke R, Flanagan T, Tanna N, Klein T, Elue R, Debosz P, Mallek J, Wright G, Guariglia P, Kang J, Gniadek TJ. 08-24-2020. Persistence of SARS-CoV-2 Nasopharyngeal Swab PCR Positivity in COVID-19 Convalescent Plasma Donors Transfusion, ,

Kam KL, Appin C, Mao Q, Ikegami S, Lukas RV, Nikiforova NM, Roy S, Brat D, Horbinski MC 07-01-2020. Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? J Neuropathol Exp Neurol, ,

Muller C, Yamada A, Ikegami S, Haider H, Komaki Y, Komaki F, Micic D, Sakuraba A 06-02-2021. Risk of colorectal cancer in serrated polyposis syndrome: A systematic review and meta-analysis Clinical Gastroenterology and Hepatology, ,

Ikegami S, Benirschke R, Fakhrai-Rad H, Motamedi M, Hockett R, David S, Lee HK, Kang J, Gniadek TJ 04-28-2021. Target specific serologic analysis of COVID-19 convalescent plasma PLoS One, ,

Klein T, Elue R, Ikegami S, Mikkelson C, Wright G, Mallek J, Kang J, Sullivan DJ, Gniadek TJ 02-10-2021. Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center with the Alyx Apheresis Collection Device Academic Pathology, ,

Shimizu S, Kadowaki M, Yoshioka H, Kambe A, Watanabe T, Kinyamu HK, Eling TE. 01-25-2013. Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells. Biochemical and Biophysical Research Communications, ,

Abstract Publications

Ikegami K, Secchia S, Almakki O, Stutzman A, Ikegami S, Ayres N, Liu SY, Lieb JD, Moskowitz IP 10-27-2020. Nuclear lamins at enhancers: a new hypothesis for laminopathies Circulation Research, ,

Kam KL, Appin C, Mao Q, Ikegami S, Nikiforova NM, Roy S, Brat D, Horbinski MC 06-01-2019. The Accuracy of Relying on Next Generation Sequencing (NGS) Alone to Diagnose Infiltrating Gliomas J Neuropathol Exp Neurol, 78 6, 520-579

Ikegami. S, Lee JP 03-15-2022. Molecular Therapeutic Target Profiles of High-Grade Ovarian Carcinomas: An Institutional Experience Modern Pathology, 102 , 760

Kam KL, Appin C, Mao Q, Ikegami S, Roy S, Brat D, Nikiforova NM, Horbinski MC 03-02-2019. The Feasibility of Relying on Next Generation Sequencing to Diagnose Gliomas. Modern Pathology, 32 2, 1-39